Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the utility of 18Fluorine Fluorodeoxyglucose Positron Emission Tomography (18FDG-PET) as a tool to quantify atherosclerotic plaque.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00703261
Study type Interventional
Source Merck Sharp & Dohme Corp.
Contact
Status Completed
Phase Phase 1
Start date August 2008
Completion date December 2009

See also
  Status Clinical Trial Phase
Completed NCT02162303 - Colchicine in Vascular Inflammation Assessed With PET Imaging Phase 2
Completed NCT03829046 - The Effects of Evolocumab in Patients With Diabetes and Atherosclerotic Vascular Disease Phase 4